You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Complement 5a receptor (C5aR)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Complement C5a Receptors in Hidradenitis Suppurativa

Recruiting
  • Hidradenitis Suppurativa
    • Redwood City, California
      Stanford University
    Jun 27, 2022

    Neuromyelitis Optica Spectrum Disorder, NMOSD, AQP4+ NMOSD Trial

    Not yet recruiting
    • Neuromyelitis Optica Spectrum Disorder
    • +2 more
      • (no location specified)
      Jul 21, 2023

      Paroxysmal Nocturnal Hemoglobinuria Trial (Danicopan)

      Recruiting
      • Paroxysmal Nocturnal Hemoglobinuria
      • Baltimore, Maryland
      • +4 more
      Feb 1, 2023

      Covid19, Thrombotic Microangiopathies, Acute Kidney Injury Trial in Boston (Ravulizumab)

      Active, not recruiting
      • Covid19
      • +2 more
      • Boston, Massachusetts
        Brigham and Women's Hospital
      Dec 31, 2022

      Generalized Myasthenia Gravis Trial (zilucoplan (RA101495))

      Not yet recruiting
      • Generalized Myasthenia Gravis
      • zilucoplan (RA101495)
      • (no location specified)
      Aug 22, 2022

      Primary Aldosteronism Trial in Montréal (Renin measurements)

      Not yet recruiting
      • Primary Aldosteronism
      • Renin measurements
      • Montréal, Quebec, Canada
        Hôpital du Sacré-Coeur de Montréal
      Oct 30, 2023

      Implication of 5-HT7 Receptor in Inflammatory Mechanisms in

      Not yet recruiting
      • Healthy
      • Multiple Sclerosis
      • Blood sample
      • Orléans, France
        CHR Orléans
      Feb 16, 2023

      Paroxysmal Nocturnal Hemoglobinuria Trial in Whittier (Ravulizumab, Pozelimab, Cemdisiran)

      Recruiting
      • Paroxysmal Nocturnal Hemoglobinuria
      • Whittier, California
      • +8 more
      Nov 29, 2022

      Paroxysmal Nocturnal Hemoglobinuria, C3 Glomerulopathy, IgA Nephropathy Trial in Korea, Republic of, New Zealand, Thailand

      Recruiting
      • Paroxysmal Nocturnal Hemoglobinuria
      • +2 more
      • Camperdown, New South Wales, Australia
      • +19 more
      Sep 13, 2022

      Advanced Solid Tumors Trial in France, United States (IPH5401 and Durvalumab)

      Terminated
      • Advanced Solid Tumors
      • IPH5401 and Durvalumab
      • Louisville, Kentucky
      • +11 more
      Jan 12, 2022

      Breast Cancer Trial in Poland, United States (ZN-c5, Abemaciclib)

      Recruiting
      • Breast Cancer
      • Gilbert, Arizona
      • +6 more
      Feb 14, 2022

      Acute Respiratory Distress Syndrome Trial in Montréal (Placebo, Ondansetron Injection)

      Not yet recruiting
      • Acute Respiratory Distress Syndrome
      • Placebo
      • Ondansetron Injection
      • Montréal, Quebec, Canada
        Hôpital Sacré-Coeur de Montréal
      Aug 22, 2022

      Multiple Myeloma Trial in New York (Infusion of MCARH109 T cells)

      Active, not recruiting
      • Multiple Myeloma
      • Infusion of MCARH109 T cells
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      Jul 5, 2022

      Breast Cancer, Chemo-induced Nausea and Vomiting Trial in Hanzhou (Aprepitant, Palonosetron, Fosaprepitant)

      Not yet recruiting
      • Breast Cancer
      • Chemotherapy-induced Nausea and Vomiting
      • Hanzhou, Zhejiang, China
        the Second Affiliated Hospital of Zhejiang Univercity School of
      Apr 23, 2023

      SARS-CoV-2 (COVID-19) Infection, Advanced or Metastatic Hematological or Solid Tumor Trial in France (Autophagy inhibitor

      Completed
      • SARS-CoV-2 (COVID-19) Infection
      • Advanced or Metastatic Hematological or Solid Tumor
      • Autophagy inhibitor (GNS651)
      • +3 more
      • Lyon, Rhône, France
      • +11 more
      Sep 29, 2022

      Paroxysmal Nocturnal Hemoglobinuria (PNH) Trial in Worldwide (Iptacopan (LNP023))

      Active, not recruiting
      • Paroxysmal Nocturnal Hemoglobinuria (PNH)
      • Iptacopan (LNP023)
      • Tianjin, Tianjin, China
      • +11 more
      Nov 21, 2022

      Bullous Pemphigoid Trial in Nice, Marseille, Montpellier (Avdoralimab (IPH5401), Control)

      Recruiting
      • Bullous Pemphigoid
      • Avdoralimab (IPH5401)
      • Control
      • Nice, Alpes-Maritimes, France
      • +3 more
      Feb 18, 2022

      Breast Cancer Stage IV, Unresectable Locally Advanced Invasive Breast Cancer, Metastatic Invasive Breast Cancer Trial in Boston

      Completed
      Has Results
      • Breast Cancer Stage IV
      • +2 more
      • Boston, Massachusetts
      • +1 more
      Oct 21, 2022

      COVID Trial in Marseille (avdoralimab, Placebo)

      Completed
      • COVID
      • avdoralimab
      • Placebo
      • Marseille, France
        Assistance Publique Hôpitaux de Marseille
      May 26, 2021

      Obesity, Morbid, Bariatric Surgery, Adolescent Trial in Aurora (Phentermine, Immediate Release Topiramate, Placebo for

      Completed
      • Obesity, Morbid
      • +4 more
      • Aurora, Colorado
        Children's Hospital Colorado
      Mar 7, 2022

      Advanced Solid Tumor Trial in Shanghai (TJ210001 Injection)

      Recruiting
      • Advanced Solid Tumor
      • TJ210001 Injection
      • Shanghai, Shanghai, China
        Shanghai East Hospital
      Jun 24, 2022

      Geographic Atrophy, Macular Degeneration Trial in Dallas (Avacincaptad pegol 2 mg intravitreal injection)

      Not yet recruiting
      • Geographic Atrophy
      • Macular Degeneration
      • Avacincaptad pegol 2 mg intravitreal injection
      • Dallas, Texas
        Retina Foundation of the Southwest
      Sep 7, 2022

      Colorectal Tumors, NSCLC, Stomach Tumors Trial (SGN-CEACAM5C)

      Not yet recruiting
      • Colorectal Neoplasms
      • +5 more
      • (no location specified)
      Nov 9, 2023

      Relapsed/Refractory Multiple Myeloma, Plasma Cell Leukemia Trial (CAR-T (CAR-GPRC5D))

      Not yet recruiting
      • Relapsed/Refractory Multiple Myeloma
      • Plasma Cell Leukemia
      • CAR-T (CAR-GPRC5D)
      • (no location specified)
      Feb 26, 2023

      Chronic Pain, Knee Pain Chronic, Post Operative Pain Trial in Toronto (Vitamin C, Placebo)

      Not yet recruiting
      • Chronic Pain
      • +2 more
      • Vitamin C
      • Placebo
      • Toronto, Ontario, Canada
      • +2 more
      Nov 7, 2023